WEBINAR - Fatty Liver NAFLD revisited - 16th September 2020.

Fatty Liver NAFLD Revisited

Fatty liver disease has been increasing year on year, paralleling the increase in waist circumference and BMI in all Western countries, if not the world. It is most often a silent process which can also lead to serious liver conditions such as cirrhosis.

As NAFLD and NASH are both considered “silent” liver disease, they are not something that will present with symptoms easily observed by a GP without screening. As current GP recommended screening examinations with increasing age do not necessarily include liver function tests, these tests may not be performed without patient request. Even if liver function tests are assessed with a metabolic panel, many physicians pass off mild elevations in alanine aminotransferase (ALT) and aspartate aminotransferase (AST) as “normal” without further testing, particularly in individuals who are overweight or obese. From the Dr’s perspective, the only recommendations they can make that may impact liver enzymes other than alcohol abstinence is weight loss, along with the proper medical management of blood sugar and cholesterol. However, NTs can encourage their clients to engage in a meaningful nutritional strategy that can and has been shown to reverse fatty liver.

During this presentation you will learn:

• About non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
• How they are diagnosed
• Who is at risk of fatty liver
• What symptoms & conditions are associated with fatty liver
• About the modifiable causes of fatty liver
• What can be done to prevent fatty liver
• About the potential role of probiotics in the development & reversal of fatty liver
• How food sensitivity can exacerbate a fatty liver
• About the key nutrients that have been shown to reverse fatty liver
• Increase your confidence in being able to successfully address fatty liver in your clients